Transgene Biotek Q2 Results
- BSE: 526139
- NSE: -
- ISIN: INE773D01018
- Sector: Biotechnology & Drugs
BSE
3.76
0.02 (0.53%)
0.02 (0.53%)Volume49.74 K
Updated: Wed 19 Mar, 2025 | 15:27:21
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Transgene Biotek Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 0.06 | 0.05 | 18.90% | 0.05 | 30.00% |
| Selling/ General/ Admin Expenses Total | 0.08 | 0.08 | 1.24% | 0.08 | 3.26% |
| Depreciation/ Amortization | 0.02 | 0.02 | 0.00% | 0.02 | 0.50% |
| Other Operating Expenses Total | 0.05 | 0.38 | -85.98% | 0.09 | -38.45% |
| Total Operating Expense | 0.16 | 0.48 | -67.29% | 0.19 | -16.25% |
| Operating Income | -0.10 | -0.44 | -77.04% | -0.14 | -30.69% |
| Net Income Before Taxes | -0.07 | 0.20 | 0.00% | -0.13 | -44.64% |
| Net Income | -0.07 | 0.20 | 0.00% | -0.13 | -44.64% |
| Diluted Normalized EPS | -0.01 | 0.03 | 0.00% | -0.02 | -50.00% |